Skip to main content
TB-500 Meds

A bold comic-panel digest of the TB-500 / thymosin beta-4 literature — what the research actually shows on tissue repair and neurological recovery, where the human data stop, and how compounded access really stands.

WRITE IN -- PANEL No.9

Contact TB-500 Meds.

Corrections, citation questions, and pointers to studies we missed. Editorial only.

Reach the editors

Correspondence is welcome on the catalog itself: a correction, a peer-reviewed study or registered trial to add, or a citation query for the full source behind a numbered card. Those notes are read and considered. The catalog cannot advise on dosing or treatment, cannot help you obtain or import the peptide, and cannot recommend a vendor or appraise a product — a reading catalog has no standing to do any of that, and such requests go unanswered.

Send a message

A contact form is provided below for written notes. Identify the page and passage where relevant and keep the message brief; substantive editorial mail is answered within roughly ten business days as volume allows. The form asks for nothing medical, legal, or commercial, and sending it creates no advisory or professional relationship with the publisher.

What we can and cannot help with

In scope: corrections, additional primary sources, and citation queries. Out of scope: medical or dosing advice, vendor or product recommendations, and legal opinions on possession or import. Messages outside the editorial scope are read but not answered, and the publisher keeps the right to leave off-topic mail unanswered.